Individualized immunosuppression in virus-negative inflammatory cardiomyopathy

Eur Heart J. 2022 Dec 1;43(45):4760. doi: 10.1093/eurheartj/ehac559.

Authors

Andrea Frustaci^{1

2}, Matteo A Russo³, Cristina Chimenti¹

Affiliations

¹ Department of Clinical, Internal, Anesthesiologist and Cardiovascular Sciences, La Sapienza University, Viale del Policlinico 155, 00161 Rome, Italy.
² Cellular and Molecular Cardiology Lab, IRCCS L. Spallanzani, 00149 Rome, Italy.
³ MEBIC Consortium, San Raffaele Open University and IRCCS San Raffaele, 00166 Rome, Italy.

PMID: 36263787
DOI: 10.1093/eurheartj/ehac559

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cardiomyopathy, Dilated*
Humans
Immunosuppression Therapy / adverse effects
Myocarditis*